Nuzenio

Eupraxia

Eupraxia news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Eupraxia Pharmaceuticals Inc (EPRX) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 18:18:17 GMTEupraxia Pharmaceuticals Inc (EPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 17:59:56 GMTEupraxia Pharmaceuticals files $300M mixed securities shelf - TipRanksTipRanks · Fri, 07 Aug 2026 09:50:23 GMTEupraxia Pharmaceuticals (NASDAQ: EPRX) sets up US$300M mixed securities shelf - Stock TitanStock Titan · Thu, 06 Aug 2026 10:27:42 GMTOne Treatment, 36 Weeks: Eupraxia's EP-104GI Shows Durable Response in Early Data as Cash Runway Extends to Late 2028 - kalkine.cakalkine.ca · Mon, 03 Aug 2026 16:16:00 GMTDavid Martin Reiterates Buy on Eupraxia Pharmaceuticals, Citing Strong KOL Support for EP-104GI’s Commercialization Potential - TipRanksTipRanks · Mon, 03 Aug 2026 16:14:47 GMTBloom Burton Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $14 - MoomooMoomoo · Mon, 03 Aug 2026 13:34:00 GMTEupraxia Pharma Partners with Pharmanovia to License Senaparib in 66 Countries Including EU; Shares Surge Over 12% - finance.biggo.comfinance.biggo.com · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:18:17 GMTEupraxia Pharmaceuticals Inc (EPRX) Stock News Today - TradingKey
Fri, 07 Aug 2026 17:59:56 GMTEupraxia Pharmaceuticals Inc (EPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 07 Aug 2026 09:50:23 GMTEupraxia Pharmaceuticals files $300M mixed securities shelf - TipRanks
Thu, 06 Aug 2026 10:27:42 GMTEupraxia Pharmaceuticals (NASDAQ: EPRX) sets up US$300M mixed securities shelf - Stock Titan
Mon, 03 Aug 2026 16:16:00 GMTOne Treatment, 36 Weeks: Eupraxia's EP-104GI Shows Durable Response in Early Data as Cash Runway Extends to Late 2028 - kalkine.ca
Mon, 03 Aug 2026 16:14:47 GMTDavid Martin Reiterates Buy on Eupraxia Pharmaceuticals, Citing Strong KOL Support for EP-104GI’s Commercialization Potential - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Eupraxia.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.